Nuclear Medicine: Page 20

BWXT Medical seeks FDA approval for Tc-99m generator

By AuntMinnie.com staff writers

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration (FDA) seeking approval of its technetium-99m (Tc-99m) generators for diagnostic imaging.

September 13, 2022

Radiopharm, MD Anderson launch new theranostics company

By AuntMinnie.com staff writers

Radiopharm Theranostics and the University of Texas MD Anderson Cancer Center (MD Anderson) have launched a new company that will develop new therapeutic radiopharmaceuticals for cancer treatment.

September 13, 2022

ARA named radiopharmaceutical 'center of excellence'

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has certified ARA Diagnostic Imaging's ARA Theranostics Center as a radiopharmaceutical therapy center of excellence.

September 13, 2022

RayzeBio makes development progress, nets $160M

By AuntMinnie.com staff writers

Radiopharmaceutical startup RayzeBio has made progress in the development of its RYZ101 targeted radiopharmaceutical candidate and secured $160 million in new financing.

September 13, 2022

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnie.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 12, 2022

Is scientific fraud rife in nuclear medicine journals?

By Will Morton

Scientific fraud may be a problem in nuclear medicine research journals, says a group in the Netherlands that conducted a recent global survey on the issue. Results were published September 8 in the Journal of Nuclear Medicine.

September 11, 2022

Interest in nuclear medicine research dips among residents

By Will Morton

Nuclear medicine's best bet to attract more physicians to the field may be to get its hooks into residents interested in recent clinical advances, according to a study published September 1 in Academic Radiology.

September 8, 2022

Health Canada approves Pluvicto for prostate cancer treatment

By AuntMinnie.com staff writers

Health Canada has approved lutetium-177 prostate-specific membrane antigen radioligand therapy (Pluvicto, Novartis) for the treatment of patients with metastatic prostate cancer.

September 7, 2022

ASNC published new guide on hybrid imaging

By AuntMinnie.com staff writers

The American Society of Nuclear Cardiology (ASNC) and three partner societies have offered new guidelines for the use of CT in hybrid nuclear/CT cardiac imaging, as published September 2 in the Journal of Nuclear Cardiology.

September 5, 2022

First patient in Oncoinvent trial treated for colorectal cancer

By AuntMinnie.com staff writers

Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate.

August 25, 2022

Anthropomorphic phantoms from Sun Nuclear bound for space

By AuntMinnie.com staff writers

A pair of Sun Nuclear anthropomorphic phantoms will travel aboard NASA's Orion spacecraft as part of an upcoming mission aimed at enabling human exploration to the moon and Mars.

August 24, 2022

AtomVie raises $40M to build new radiopharmaceutical facility

By AuntMinnie.com staff writers

AtomVie Global Radiopharma has received at least $40 million in financing that will be used to build a new facility to expand its radiopharmaceutical manufacturing.

August 23, 2022

Previous Page

Page 20 of 440

Next Page